Convalescent plasma use against epidemic respiratory viruses dates back to the influenza pandemic of 1918. This intervention has persisted for over a century based on high face-validity, rather than any high-quality evidence. The COVID epidemic reignited enthusiasm for this therapy, leading to its use in tens of thousands of patients (e.g., an expanded-use program organized […]
EMCrit Project by Josh Farkas.
No comments:
Post a Comment